A 52-year-old man undergoing interscalene block for shoulder surgery receives 20 mL of 0.5% bupivacaine. At 8 minutes, he develops circumoral numbness, tinnitus, and mild tremor. At 12 minutes, he has a brief seizure. Which finding best distinguishes this CNS-predominant toxicity from a case where CV toxicity would be the primary concern?

Explanation

## CNS-Predominant vs CV-Predominant LAST ### Clinical Presentation in This Case The patient exhibits the classic **CNS-predominant** pattern: - Prodromal signs: circumoral numbness, tinnitus (hallmark early warnings) - Tremor and restlessness (CNS stimulation) - **Seizure at 12 minutes** (peak CNS toxicity) - Vital signs initially preserved **Key Point:** The presence of seizure activity *before* hemodynamic collapse is the defining feature of CNS-predominant toxicity and indicates the toxin concentration is still in the CNS-sensitive range. ### Comparison: CNS-Predominant vs CV-Predominant LAST | Feature | CNS-Predominant | CV-Predominant | |---|---|---| | **Prodrome** | Circumoral numbness, tinnitus, tremor | Often absent or minimal | | **First major sign** | Seizure (15–20 μg/mL) | Bradycardia, hypotension, arrhythmia (>25 μg/mL) | | **Hemodynamics early** | Relatively preserved | Rapidly deteriorates | | **Mechanism** | Excitation of inhibitory pathways in CNS | Direct myocardial depression, conduction block | | **Prognosis if caught early** | Excellent with airway control + lipid | Worse; requires prolonged resuscitation | ### Clinical Pearl **High-Yield:** The **seizure without prior hemodynamic collapse** is the cardinal sign that you have caught LAST in its CNS phase. This is a therapeutic window—aggressive airway management and lipid emulsion therapy at this point prevent progression to cardiac arrest. In contrast, if the patient had presented with **sudden bradycardia, hypotension, and arrhythmia without preceding seizure**, you would suspect CV-predominant toxicity (e.g., from rapid IV injection of a large bolus, or in a patient with underlying cardiac disease). ### Why This Matters Recognizing CNS-predominant toxicity early allows: 1. Seizure management (airway, benzodiazepines) 2. Lipid emulsion infusion before cardiac arrest 3. Prevention of progression to CV collapse **Mnemonic: SEIZE First, STOP Injection** — **S**eizure (CNS toxicity) → **E**arly recognition → **I**ntervention (lipid, airway) → **Z**ero progression to cardiac arrest → **E**xcellent outcome.